Cytoreductive surgery and hyperthermic intrathoracic chemotherapy perfusion for malignant pleural tumours: Perioperative management and clinical experience

European Journal of Cardio-thoracic Surgery

Volumn 43, Issue 4, 2013, Pages 801-807

  Ried, Michael ^a   Potzger, Tobias ^a   Braune, Nico ^a   Neu, Reiner ^a   Zausig, York ^a   Schalke, Berthold ^b   Diez, Claudius ^a   Hofmann, Hans Stefan ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Cytoreductive surgery; Hyperthermic perfusion; Multimodality treatment; Pleural mesothelioma; Thymoma

Indexed keywords

CISPLATIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CYTOREDUCTIVE SURGERY; DECORTICATION; DISEASE SEVERITY; DRUG DOSE INCREASE; EPIDURAL ANESTHESIA; FEMALE; FOLLOW UP; GENERAL ANESTHESIA; HIGH TEMPERATURE; HOSPITALIZATION; HUMAN; HYPERTHERMIC INTRATHORACIC CHEMOTHERAPY PERFUSION; INTENSIVE CARE UNIT; LENGTH OF STAY; MALE; MORBIDITY; PATIENT CARE; PERIOPERATIVE PERIOD; PLEURA MESOTHELIOMA; PLEURECTOMY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; REOPERATION; SURGICAL MORTALITY; SURVIVAL RATE; SURVIVAL TIME; THYMOMA;

AGED; ANTINEOPLASTIC AGENTS; CISPLATIN; COMBINED MODALITY THERAPY; FEASIBILITY STUDIES; HUMANS; HYPERTHERMIA, INDUCED; MALE; MESOTHELIOMA; MIDDLE AGED; PLEURAL NEOPLASMS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; THORACIC SURGICAL PROCEDURES; THYMOMA; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84875591329     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezs418     Document Type: Article

References (25)

1. Peto J, Decarli A, La Vecchia C, Levi F, Negri E. The European mesothelioma epidemic. Br J Cancer 1999;79:666-72.
2. Muers MF, Stevens RJ, Fisher P, Darlison L, Higgs CM, Lowry E et al.; MS01 Trial Management Group. Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomized trial. Lancet 2008;371:1658-94.
3. Zauderer MG, Krug LM. The evolution of multimodality therapy for malignant pleural mesothelioma. Curr Treat Options Oncol 2011;12:163-72.
4. Ruffini E, Van Raemdonck D, Detterbeck F, Rocco G, Thomas P, Venuta F. Management of thymic tumors: a survey of current practice among members of the European Society of Thoracic Surgeons. J Thorac Oncol 2011;6:614-23.
5. Rena O, Mineo TC, Casadio C. Multimodal treatment for stage IVA thymoma: a proposable strategy. Lung Cancer 2012;76:89-92.
6. Kaufman AJ, Flores RM. Surgical treatment of malignant pleural mesothelioma. Curr Treat Options Oncol 2011;12:201-6.
7. Yang HC, Yoon YS, Kim HK, Choi YS, Kim K, Shim YM et al. En bloc extended total thymectomy and extrapleural pneumonectomy in Masaoka stage IVA thymomas. J Cardiothorac Surg 2011;6:1-5.
8. Flores M. Surgical options in malignant pleural mesothelioma: extrapleural pneumonectomy or pleurectomy/decortication. Semin Thorac Cardiovasc Surg 2009;21:149-53.
9. Rice D, Rusch V, Pass H, Asamura H, Nakano T, Edwards J et al. Recommendations for uniform definitions of surgical techniques for malignant pleural mesothelioma: a consensus report of the international association for the study of Lung Cancer International Staging Committee and the International Mesothelioma Interest Group. J Thorac Oncol 2011;6:1304-12.
10. Flores RM, Pass HI, Seshan VE, Dycoco J, Zakowski M, Carbone M et al. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. J Thorac Cardiovasc Surg 2008;135:620-6.
11. Van Ruth S, Baas P, Haas R, Rutgers E, Verwaal V, Zoetmulder FA. Cytoreductive surgery combined with intraoperative hyperthermic intrathoracic chemotherapy for stage I malignant pleural mesothelioma. Ann Surg Oncol 2003;10:176-82.
12. Yellin A, Simansky DA, Paley M, Refaely Y. Hyperthermic pleural perfusion with cisplatin: early clinical experience. Cancer 2001;92:2197-203.
13. Ratto GB, Civalleri D, Esposito M, Spessa E, Alloisio A, De Cian F et al. Pleural space perfusion with cisplatin in the multimodality treatment of malignant mesothelioma: a feasibility and pharmacokinetic study. J Thorac Cardiovasc Surg 1999;117:759-65.
14. De Bree E, van Ruth S, Baas P, Rutgers EJ, van Zandwijk N, Witkamp AJ et al. Cytoreductive surgery and intraoperative hyperthermic intrathoracic chemotherapy in patients with malignant pleural mesothelioma or pleural metastases of thymoma. Chest 2002;121:480-7.
15. Treasure T, Waller D, Tan C, Entwisle J, O'Brien M, O'Byrne K et al. The mesothelioma and radical surgery randomized controlled trial: the MARS feasibility study. J Thorac Oncol 2009;10:1254-8.
16. Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 2003;21:2636-44.
17. Weder W, Stahel RA, Bernhard J, Bodis S, Vogt P, Ballabeni P et al. Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. Ann Oncol 2007; 18:1196-202.
18. Krug LM, Pass HI, Rusch VW, Kindler HL, Sugarbaker DJ, Rosenzweig KE et al. Multicenter phase II trial of neoadjuvant pemetrexed lus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma. J Clin Oncol 2009;27:3007-13.
19. Richards WG, Zellos L, Bueno R, Jaklitsch MT, Jänne PA, Chirieac LR et al. Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma. J Clin Oncol 2006;24:1561-67.
20. Bolubkas S, Manegold C, Eberlein M, Bergmann T, Fisseler-Eckhoff A, Schirren J. Survival after trimodality therapy for malignant pleural mesothelioma: radical pleurectomy, chemotherapy with cisplatin/pemetrexed and radiotherapy. Lung Cancer 2009;71:75-81.
21. Rusch VW, Niedzwiecki D, Tao Y, Menendez-Botet C, Dnistrian A, Kelsen D et al. Intrapleural cisplatin and mitomycin for malignant mesothelioma following pleurectomy: pharmacokinetic studies. J Clin Oncol 1992;10: 1001-6.
22. Zellos L, Richards WG, Capalbo L, Jaklitsch MT, Chirieac LR, Johnson BE et al. A phase I study of extrapleural pneumonectomy and intracavitary intraoperative hyperthermic cisplatin with amifostine cytoprotection for malignant mesothelioma. J Thorac Cardiovasc Surg 2009;137: 453-8.
23. Tillemann TR, Richards WG, Zellos L, Johnson BE, Jaklitsch MT, Mueller J et al. Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective study. J Thorac Cardiovasc Surg 2009;138:405-11.
24. Gonzales M, Krueger T, Perentes JY, Matzinger O, Peters S, Ris HB. Extrapleural pneumonectomy with venous confluence resection for stage IVa thymic tumors. Ann Thorac Surg 2011;91:941-3.
25. Refaely Y, Simansky DA, Paley M, Gottfried M, Yellin A. Resection and perfusion thermochemotherapy: A new approach for the treatment of thymic malignancies with pleural spread. Ann Thorac Surg 2001;72: 366-70.